$PLPL News- Plandai Biotechnology In Non-Binding Letter of Intent to Acquire Rights to Puriblood’s Leukocyte Reduction Blood Filtration System ( FDA APPROVED ) with Plans to Address the International Blood Filtration Market

$PLPL FDA Approved (Puriblood in Taiwan has a market value of $65 million. And they only have Taiwan. $PLPL has all of North, Central and South America)

$FDA APPROVED #MONKEYPOX #COVID #COVID19 #BLOOD #VIRUS

https://www.accesswire.com/702221/Plandai-Bio...ion-Market